Risk Factors Associated with Hospitalization for Influenza

Author(s)

Chitnis A1, Krishnan D2, Johnson BH1, Wood J1, Holy C3, Hartzell R4, Chen J4, Snyder Q4, Bommarito K4, Putnam M5
1Johnson & Johnson, New Brunswick, NJ, USA, 2Mu Sigma, Bengaluru, KA, India, 3Johnson & Johnson, Somerville, MA, USA, 4Mercy Health, St Louis, MO, USA, 5Johnson & Johnson Medical Device, West Chester, PA, USA

OBJECTIVES : Influenza has resulted in between 140,000 – 810,000 hospitalizations annually since 2010 placing a substantial health burden on people in the United States each year. This study evaluated the risk factors associated with hospitalization among patients with influenza in a real-world setting.

METHODS : Patients with a diagnosis of influenza between 2016-2020 were identified from the Mercy Health electronic health records, which is comprehensive and longitudinal. Hospitalization for influenza was defined as hospitalization on or within 14 days after first influenza diagnosis. Multivariate logistic regression was conducted to determine the risk factors including patient demographics and behaviors, comorbidities, and medications associated with hospitalization.

RESULTS : A total of 65,871 patients (mean age 37 years, 56% female) with influenza were identified. Among demographics and behaviors, older age [age 51-75 and 75+ years vs 22-50 years, Odds ratio (OR), 95% Confidence Interval (95% CI): 1.7, 1.3-2.2 and 2.0, 1.4-3.0, respectively], and current tobacco use (OR, 95% CI: 1.6, 1.3-2.1) significantly increased the risk of hospitalization. Among comorbidities, the significant factors were necrotic conditions of lower respiratory tract (OR, 95% CI: 7.6, 1.4-43.5), paralysis (OR, 95%CI: 5.4, 1.9-15.9), respiratory disorders (OR, 95% CI: 4.7, 3.5-6.3), coagulopathy (OR, 95%CI: 3.0, 1.9-4.6), hypertension (OR, 95% CI: 1.8, 1.3-2.6), anemia (OR, 95% CI: 1.8, 1.2-2.7), neurologic disorders (OR, 95% CI: 1.7, 1.1-2.5), diabetes (OR, 95% CI: 1.6, 1.2-2.1), and renal failure (OR, 95% CI: 1.4, 1.1-1.9). Among medication use, antivirals (OR, 95% CI: 1.8, 1.2-2.7), opioids (OR, 95% CI: 1.6, 1.2-2.0), and antihyperglycemics (OR, 95% CI: 1.5, 1.1-2.1) significantly increased the risk of hospitalization.

CONCLUSIONS : This real-world study identified certain patient demographic (age), behavior (tobacco use), comorbidity (respiratory disorder, paralysis, coagulopathy, hypertension, anemia, neurologic disorders, diabetes, renal failure) and medication use (antiviral, opioid, antihyperglycemic) that were significantly associated with hospitalization among patients with a diagnosis of influenza.

Conference/Value in Health Info

2020-11, ISPOR Europe 2020, Milan, Italy

Value in Health, Volume 23, Issue S2 (December 2020)

Code

PRS42

Topic

Epidemiology & Public Health

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×